79 Works
Additional file 2 of Changes in HER3 expression profiles between primary and recurrent gynecological cancers
Yuki Kojima, Kazuki Sudo, Hiroshi Yoshida, Shu Yazaki, Momoko Tokura, Chiharu Mizoguchi, Hitomi S. Okuma, Shosuke Kita, Kasumi Yamamoto, Tadaaki Nishikawa, Emi Noguchi, Tatsunori Shimoi, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato, Kumiko Koyama, Maki Kobayashi, Tomoya Kakegawa, Yasuhiro Fujiwara & Kan Yonemori
Additional file 2: Table S2. Patient characteristics of endometrial cancer
Additional file 6 of Changes in HER3 expression profiles between primary and recurrent gynecological cancers
Yuki Kojima, Kazuki Sudo, Hiroshi Yoshida, Shu Yazaki, Momoko Tokura, Chiharu Mizoguchi, Hitomi S. Okuma, Shosuke Kita, Kasumi Yamamoto, Tadaaki Nishikawa, Emi Noguchi, Tatsunori Shimoi, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato, Kumiko Koyama, Maki Kobayashi, Tomoya Kakegawa, Yasuhiro Fujiwara & Kan Yonemori
Additional file 6: Table S6. HER3 expression in cervical cancer at initial diagnosis
Additional file 4 of Changes in HER3 expression profiles between primary and recurrent gynecological cancers
Yuki Kojima, Kazuki Sudo, Hiroshi Yoshida, Shu Yazaki, Momoko Tokura, Chiharu Mizoguchi, Hitomi S. Okuma, Shosuke Kita, Kasumi Yamamoto, Tadaaki Nishikawa, Emi Noguchi, Tatsunori Shimoi, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato, Kumiko Koyama, Maki Kobayashi, Tomoya Kakegawa, Yasuhiro Fujiwara & Kan Yonemori
Additional file 4: Table S4. HER3 expression in ovarian cancer at initial diagnosis
Additional file 5 of Changes in HER3 expression profiles between primary and recurrent gynecological cancers
Yuki Kojima, Kazuki Sudo, Hiroshi Yoshida, Shu Yazaki, Momoko Tokura, Chiharu Mizoguchi, Hitomi S. Okuma, Shosuke Kita, Kasumi Yamamoto, Tadaaki Nishikawa, Emi Noguchi, Tatsunori Shimoi, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato, Kumiko Koyama, Maki Kobayashi, Tomoya Kakegawa, Yasuhiro Fujiwara & Kan Yonemori
Additional file 5: Table S5. HER3 expression in endometrial cancer at initial diagnosis
sj-docx-1-jbm-10.1177_03936155231165068 - Supplemental material for MMR markers correlate with clinical outcome in patients with esophageal squamous cell carcinoma
Takuro Yamauchi, Fumiyoshi Fujishima, Junichi Tsunokake, Atsushi Kunimitsu, Ryujiro Akaishi, Yohei Ozawa, Toshiaki Fukutomi, Hiroshi Okamoto, Chiaki Sato, Yusuke Taniyama, Takashi Kamei, Ryo Ichinohasama & Hironobu Sasano
Supplemental material, sj-docx-1-jbm-10.1177_03936155231165068 for MMR markers correlate with clinical outcome in patients with esophageal squamous cell carcinoma by Takuro Yamauchi, Fumiyoshi Fujishima, Junichi Tsunokake, Atsushi Kunimitsu, Ryujiro Akaishi, Yohei Ozawa, Toshiaki Fukutomi, Hiroshi Okamoto, Chiaki Sato, Yusuke Taniyama, Takashi Kamei, Ryo Ichinohasama and Hironobu Sasano in The International Journal of Biological Markers
Additional file 1 of Cancer aggravation due to persistent pain signals with the increased expression of pain-related mediators in sensory neurons of tumor-bearing mice
Kenichi Tanaka, Takashige Kondo, Michiko Narita, Takeru Muta, Sara Yoshida, Daisuke Sato, Yukari Suda, Yusuke Hamada, Takatsune Shimizu, Naoko Kuzumaki & Minoru Narita
Additional file 1: Table S1. Details of RT-qPCR primer.
Additional file 1 of Complementary prognostic value of stress perfusion imaging and global coronary flow reserve derived from cardiovascular magnetic resonance: a long-term cohort study
Satoshi Nakamura, Masaki Ishida, Kei Nakata, Masafumi Takafuji, Shiro Nakamori, Tairo Kurita, Haruno Ito, Kaoru Dohi & Hajime Sakuma
Additional file 1: Figure S1. Long-term risk stratification for MACE in patients with known CAD. Figure S2. Long-term risk stratification for MACE in patients with suspected CAD. Figure S3. Long-term risk stratification for MACE in patients who underwent 1.5T CMR. Figure S4. Long-term risk stratification for MACE in patients who underwent 3T CMR. Figure S5. Bland–Altman plot for CFR measurement. Table S1. Cox proportional hazard regression analysis for prediction of MACE in patients with known...
Additional file 1 of Repression of the PRELP gene is relieved by histone deacetylase inhibitors through acetylation of histone H2B lysine 5 in bladder cancer
Kanto Shozu, Syuzo Kaneko, Norio Shinkai, Ai Dozen, Hirofumi Kosuge, Makoto Nakakido, Hidenori Machino, Ken Takasawa, Ken Asada, Masaaki Komatsu, Kouhei Tsumoto, Shin-Ichi Ohnuma & Ryuji Hamamoto
Additional file 1: It includes supplementary Figs. 1–8 and supplementary raw data 1–3
Integrative pathway enrichment analysis of multivariate omics data
Marta Paczkowska, Jonathan Barenboim, Nardnisa Sintupisut, Natalie S Fox, Helen Zhu, Diala Abd-Rabbo, Miles W Mee, Paul C Boutros, Federico Abascal, Samirkumar B Amin, Gary D Bader, Rameen Beroukhim, Johanna Bertl, Keith A Boroevich, Søren Brunak, Peter J Campbell, Joana Carlevaro-Fita, Dimple Chakravarty, Calvin Wing Yiu Chan, Ken Chen, Jung Kyoon Choi, Jordi Deu-Pons, Priyanka Dhingra, Klev Diamanti, Lars Feuerbach … & L van’t Veer
Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high-dimensional molecular profiles pose challenges to data interpretation and hypothesis generation. ActivePathways is an integrative method that discovers significantly enriched pathways across multiple datasets using statistical data fusion, rationalizes contributing evidence and highlights associated genes. As part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2658 cancers across 38 tumor types, we integrated...
sj-docx-2-ijs-10.1177_10668969221133348 - Supplemental material for Uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge
Takashi Natsume, Hiroshi Yoshida, Tadaaki Nishikawa, Nao Kikkawa, Tomoaki Naka, Mayumi Kobayashi-Kato, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa & Tomoyasu Kato
Supplemental material, sj-docx-2-ijs-10.1177_10668969221133348 for Uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge by Takashi Natsume, Hiroshi Yoshida and Tadaaki Nishikawa, Nao Kikkawa, Tomoaki Naka, Mayumi Kobayashi-Kato, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato in International Journal of Surgical Pathology
sj-docx-1-ijs-10.1177_10668969231177256 - Supplemental material for Ovarian Mucinous Tumor Presenting Atypical Lobular Endocervical Glandular Hyperplasia-Like Appearance in a Patient With Germline STK11 p.F354L Variant: A Case Report
Hiroshi Yoshida, Kengo Hiranuma, Mariko Nakahara, Mayumi Kobayashi-Kato, Yasuhito Tanase, Masaya Uno, Kouya Shiraishi, Mitsuya Ishikawa & Tomoyasu Kato
Supplemental material, sj-docx-1-ijs-10.1177_10668969231177256 for Ovarian Mucinous Tumor Presenting Atypical Lobular Endocervical Glandular Hyperplasia-Like Appearance in a Patient With Germline STK11 p.F354L Variant: A Case Report by Hiroshi Yoshida, Kengo Hiranuma, Mariko Nakahara, Mayumi Kobayashi-Kato, Yasuhito Tanase, Masaya Uno, Kouya Shiraishi, Mitsuya Ishikawa and Tomoyasu Kato in International Journal of Surgical Pathology
sj-docx-2-jbm-10.1177_03936155231165068 - Supplemental material for MMR markers correlate with clinical outcome in patients with esophageal squamous cell carcinoma
Takuro Yamauchi, Fumiyoshi Fujishima, Junichi Tsunokake, Atsushi Kunimitsu, Ryujiro Akaishi, Yohei Ozawa, Toshiaki Fukutomi, Hiroshi Okamoto, Chiaki Sato, Yusuke Taniyama, Takashi Kamei, Ryo Ichinohasama & Hironobu Sasano
Supplemental material, sj-docx-2-jbm-10.1177_03936155231165068 for MMR markers correlate with clinical outcome in patients with esophageal squamous cell carcinoma by Takuro Yamauchi, Fumiyoshi Fujishima, Junichi Tsunokake, Atsushi Kunimitsu, Ryujiro Akaishi, Yohei Ozawa, Toshiaki Fukutomi, Hiroshi Okamoto, Chiaki Sato, Yusuke Taniyama, Takashi Kamei, Ryo Ichinohasama and Hironobu Sasano in The International Journal of Biological Markers
Additional file 1 of Cancer aggravation due to persistent pain signals with the increased expression of pain-related mediators in sensory neurons of tumor-bearing mice
Kenichi Tanaka, Takashige Kondo, Michiko Narita, Takeru Muta, Sara Yoshida, Daisuke Sato, Yukari Suda, Yusuke Hamada, Takatsune Shimizu, Naoko Kuzumaki & Minoru Narita
Additional file 1: Table S1. Details of RT-qPCR primer.
Additional file 1 of Complementary prognostic value of stress perfusion imaging and global coronary flow reserve derived from cardiovascular magnetic resonance: a long-term cohort study
Satoshi Nakamura, Masaki Ishida, Kei Nakata, Masafumi Takafuji, Shiro Nakamori, Tairo Kurita, Haruno Ito, Kaoru Dohi & Hajime Sakuma
Additional file 1: Figure S1. Long-term risk stratification for MACE in patients with known CAD. Figure S2. Long-term risk stratification for MACE in patients with suspected CAD. Figure S3. Long-term risk stratification for MACE in patients who underwent 1.5T CMR. Figure S4. Long-term risk stratification for MACE in patients who underwent 3T CMR. Figure S5. Bland–Altman plot for CFR measurement. Table S1. Cox proportional hazard regression analysis for prediction of MACE in patients with known...
Additional file 1 of Changes in HER3 expression profiles between primary and recurrent gynecological cancers
Yuki Kojima, Kazuki Sudo, Hiroshi Yoshida, Shu Yazaki, Momoko Tokura, Chiharu Mizoguchi, Hitomi S. Okuma, Shosuke Kita, Kasumi Yamamoto, Tadaaki Nishikawa, Emi Noguchi, Tatsunori Shimoi, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato, Kumiko Koyama, Maki Kobayashi, Tomoya Kakegawa, Yasuhiro Fujiwara & Kan Yonemori
Additional file 1: Table S1. Patient characteristics of ovarian cancer
Additional file 4 of Changes in HER3 expression profiles between primary and recurrent gynecological cancers
Yuki Kojima, Kazuki Sudo, Hiroshi Yoshida, Shu Yazaki, Momoko Tokura, Chiharu Mizoguchi, Hitomi S. Okuma, Shosuke Kita, Kasumi Yamamoto, Tadaaki Nishikawa, Emi Noguchi, Tatsunori Shimoi, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato, Kumiko Koyama, Maki Kobayashi, Tomoya Kakegawa, Yasuhiro Fujiwara & Kan Yonemori
Additional file 4: Table S4. HER3 expression in ovarian cancer at initial diagnosis
Additional file 5 of Changes in HER3 expression profiles between primary and recurrent gynecological cancers
Yuki Kojima, Kazuki Sudo, Hiroshi Yoshida, Shu Yazaki, Momoko Tokura, Chiharu Mizoguchi, Hitomi S. Okuma, Shosuke Kita, Kasumi Yamamoto, Tadaaki Nishikawa, Emi Noguchi, Tatsunori Shimoi, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato, Kumiko Koyama, Maki Kobayashi, Tomoya Kakegawa, Yasuhiro Fujiwara & Kan Yonemori
Additional file 5: Table S5. HER3 expression in endometrial cancer at initial diagnosis
Combined burden and functional impact tests for cancer driver discovery using DriverPower
Shimin Shuai, Federico Abascal, Samirkumar B Amin, Gary D Bader, Pratiti Bandopadhayay, Jonathan Barenboim, Rameen Beroukhim, Johanna Bertl, Keith A Boroevich, Søren Brunak, Peter J Campbell, Joana Carlevaro-Fita, Dimple Chakravarty, Calvin Wing Yiu Chan, Ken Chen, Jung Kyoon Choi, Jordi Deu-Pons, Priyanka Dhingra, Klev Diamanti, Lars Feuerbach, J Lynn Fink, Nuno A Fonseca, Joan Frigola, Carlo Gambacorti-Passerini, Dale W Garsed … & L van’t Veer
The discovery of driver mutations is one of the key motivations for cancer genome sequencing. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2658 cancers across 38 tumour types, we describe DriverPower, a software package that uses mutational burden and functional impact evidence to identify driver mutations in coding and non-coding sites within cancer whole genomes. Using a total of 1373 genomic features...
Pathway and network analysis of more than 2500 whole cancer genomes
Matthew A Reyna, David Haan, Marta Paczkowska, Lieven PC Verbeke, Miguel Vazquez, Abdullah Kahraman, Sergio Pulido-Tamayo, Jonathan Barenboim, Lina Wadi, Priyanka Dhingra, Raunak Shrestha, Gad Getz, Michael S Lawrence, Jakob Skou Pedersen, Mark A Rubin, David A Wheeler, Søren Brunak, Jose MG Izarzugaza, Ekta Khurana, Kathleen Marchal, Christian von Mering, S Cenk Sahinalp, Alfonso Valencia, Federico Abascal, Samirkumar B Amin … & L van’t Veer
The catalog of cancer driver mutations in protein-coding genes has greatly expanded in the past decade. However, non-coding cancer driver mutations are less well-characterized and only a handful of recurrent non-coding mutations, most notably TERT promoter mutations, have been reported. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2658 cancer across 38 tumor types, we perform multi-faceted pathway and network analyses of non-coding...
Pathway and network analysis of more than 2500 whole cancer genomes
Matthew A Reyna, David Haan, Marta Paczkowska, Lieven PC Verbeke, Miguel Vazquez, Abdullah Kahraman, Sergio Pulido-Tamayo, Jonathan Barenboim, Lina Wadi, Priyanka Dhingra, Raunak Shrestha, Gad Getz, Michael S Lawrence, Jakob Skou Pedersen, Mark A Rubin, David A Wheeler, Søren Brunak, Jose MG Izarzugaza, Ekta Khurana, Kathleen Marchal, Christian von Mering, S Cenk Sahinalp, Alfonso Valencia, Federico Abascal, Samirkumar B Amin … & L van’t Veer
The catalog of cancer driver mutations in protein-coding genes has greatly expanded in the past decade. However, non-coding cancer driver mutations are less well-characterized and only a handful of recurrent non-coding mutations, most notably TERT promoter mutations, have been reported. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2658 cancer across 38 tumor types, we perform multi-faceted pathway and network analyses of non-coding...
Integrative pathway enrichment analysis of multivariate omics data
Marta Paczkowska, Jonathan Barenboim, Nardnisa Sintupisut, Natalie S Fox, Helen Zhu, Diala Abd-Rabbo, Miles W Mee, Paul C Boutros, Federico Abascal, Samirkumar B Amin, Gary D Bader, Rameen Beroukhim, Johanna Bertl, Keith A Boroevich, Søren Brunak, Peter J Campbell, Joana Carlevaro-Fita, Dimple Chakravarty, Calvin Wing Yiu Chan, Ken Chen, Jung Kyoon Choi, Jordi Deu-Pons, Priyanka Dhingra, Klev Diamanti, Lars Feuerbach … & L van’t Veer
Multi-omics datasets represent distinct aspects of the central dogma of molecular biology. Such high-dimensional molecular profiles pose challenges to data interpretation and hypothesis generation. ActivePathways is an integrative method that discovers significantly enriched pathways across multiple datasets using statistical data fusion, rationalizes contributing evidence and highlights associated genes. As part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2658 cancers across 38 tumor types, we integrated...
sj-docx-1-ijs-10.1177_10668969221133348 - Supplemental material for Uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge
Takashi Natsume, Hiroshi Yoshida, Tadaaki Nishikawa, Nao Kikkawa, Tomoaki Naka, Mayumi Kobayashi-Kato, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa & Tomoyasu Kato
Supplemental material, sj-docx-1-ijs-10.1177_10668969221133348 for Uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge by Takashi Natsume, Hiroshi Yoshida and Tadaaki Nishikawa, Nao Kikkawa, Tomoaki Naka, Mayumi Kobayashi-Kato, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato in International Journal of Surgical Pathology
sj-docx-2-ijs-10.1177_10668969221133348 - Supplemental material for Uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge
Takashi Natsume, Hiroshi Yoshida, Tadaaki Nishikawa, Nao Kikkawa, Tomoaki Naka, Mayumi Kobayashi-Kato, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa & Tomoyasu Kato
Supplemental material, sj-docx-2-ijs-10.1177_10668969221133348 for Uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge by Takashi Natsume, Hiroshi Yoshida and Tadaaki Nishikawa, Nao Kikkawa, Tomoaki Naka, Mayumi Kobayashi-Kato, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato in International Journal of Surgical Pathology
Additional file 1 of Effect modification by geographic area on the association between health literacy and self-rated health: a nationwide cross-sectional study in Japan
Hirono Ishikawa, Runa Ogawa, Aki Otsuki, Junko Saito, Akiko Yaguchi-Saito, Aya Kuchiba, Maiko Fujimori, Yoshiharu Fukuda & Taichi Shimazu
Additional file 1: Supplementary Table 1. Health literacy score measured with CCHL in previous studies with Japanese general population.
sj-docx-1-icr-10.1177_11795476221131189 – Supplemental material for Primary Intracranial Spindle Cell Sarcoma, DICER1-Mutant, with MDM2 Amplification Diagnosed on the Basis of Extensive Molecular Profiling
Takahide Nejo, Shunsaku Takayanagi, Shota Tanaka, Aya Shinozaki-Ushiku, Shinji Kohsaka, Keisuke Nagata, Munehiro Yokoyama, Shigeo Sora, Tetsuo Ushiku, Akitake Mukasa, Hiroyuki Aburatani, Hiroyuki Mano & Nobuhito Saito
Supplemental material, sj-docx-1-icr-10.1177_11795476221131189 for Primary Intracranial Spindle Cell Sarcoma, DICER1-Mutant, with MDM2 Amplification Diagnosed on the Basis of Extensive Molecular Profiling by Takahide Nejo, Shunsaku Takayanagi, Shota Tanaka, Aya Shinozaki-Ushiku, Shinji Kohsaka, Keisuke Nagata, Munehiro Yokoyama, Shigeo Sora, Tetsuo Ushiku, Akitake Mukasa, Hiroyuki Aburatani, Hiroyuki Mano and Nobuhito Saito in Clinical Medicine Insights: Case Reports
Affiliations
-
National Cancer Centre79
-
University of Tokyo36
-
Jikei University School of Medicine22
-
Saitama International Medical Center17
-
Kyoto University16
-
Qinghai University Affiliated Hospital12
-
University of Tennessee Health Science Center12
-
Affiliated Hospital of Southwest Medical University12
-
Jiangsu Academy of Agricultural Sciences12
-
Affiliated Hospital of Nantong University12